Frequency of the transthyretin Val30Met mutation in the northern Swedish population

被引:21
|
作者
Olsson, Malin [1 ]
Jonasson, Jenni [2 ]
Cederquist, Kristina [2 ]
Suhr, Ole B. [1 ]
机构
[1] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden
[2] Umea Univ Hosp, Dept Clin Genet Lab Med, S-90185 Umea, Sweden
来源
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2014年 / 21卷 / 01期
关键词
Amyloidosis-hereditary-neuropathic; ATTRV30M (p.ATTRV50M); frequency; genotyping; mutation; transthyretin; TTR c.(Val50Met); POLYNEUROPATHY;
D O I
10.3109/13506129.2013.860027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By genotyping a large number of samples from the Northern Sweden Health and Disease Study cohort, a carrier frequency could be determined for the Skelleftea and Lycksele populations. A previous study of the amyloidogenic transthyretin mutation TTRV30M in Northern Sweden's endemic area has shown a large variation in carrier frequency and penetrance of the trait within the area. However, the estimations have been based on a small sample size within the different regions in the area and therefore, the wide variation in TTRV30M carrier frequency observed between the Lycksele and Skelleftea populations are uncertain. Based on a total of 3460 samples, the estimated overall carrier frequency in the two regions was 1.82% with a carrier frequency in the Skelleftea and Lycksele population of 1.63% and 2.02%, respectively. Thus, the previously reported extremely high frequency in the Lycksele region compared to that of the Skelleftea region could not be substantiated. However, it does not change the previous finding of a surprisingly higher carrier frequency in the population from endemic area of Northern Sweden compared to that reported from endemic areas in Portugal.
引用
收藏
页码:18 / 20
页数:3
相关论文
共 50 条
  • [11] Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area
    Andres, N.
    Poza, J. J.
    Marti Masso, J. F.
    NEUROLOGIA, 2018, 33 (09): : 583 - 589
  • [12] Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy
    Taguchi, Kazuaki
    Jono, Hirofumi
    Kugimiya-Taguchi, Tomoe
    Nagao, Saori
    Su, Yu
    Yamasaki, Keishi
    Mizuguchi, Mineyuki
    Maruyama, Toru
    Ando, Yukio
    Otagiri, Masaki
    LIFE SCIENCES, 2013, 93 (25-26) : 1017 - 1022
  • [13] Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant
    Palácios, SA
    Bittencourt, PL
    Cançado, ELR
    Farias, AQ
    Massarollo, PCB
    Mies, S
    Kalil, J
    Goldberg, AC
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (04): : 289 - 291
  • [14] Tafamidis delays neurological progression comparably across Val30Met and non-Val30Met genotypes in transthyretin familial amyloid polyneuropathy
    Gundapaneni, B. K.
    Sultan, M. B.
    Keohane, D. J.
    Schwartz, J. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (03) : 464 - 468
  • [15] Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met) - comparison of Swedish and Japanese patients
    Tashima, K
    Suhr, OB
    Ando, Y
    Holmgren, G
    Yamashita, T
    Obayashi, K
    Terazaki, H
    Uchino, M
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 1999, 6 (02): : 124 - 129
  • [16] Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis
    Anan, Intissar
    Suhr, Ole B.
    Liszewska, Katarzyna
    Baranda, Jorge Mejia
    Pilebro, Bjorn
    Wixner, Jonas
    Ihse, Elisabet
    PLOS ONE, 2022, 17 (03):
  • [17] Postmortem findings in a familial amyloid polyneuropathy patient with homozygosity of the mutant Val30Met transthyretin gene
    Yoshinaga, T
    Takei, YI
    Katayanagi, K
    Ikeda, SI
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2004, 11 (01): : 56 - 60
  • [18] Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy
    Sanso, Maria Antonia Ribot
    Rodriguez, Adrian Rodriguez
    Vicente, Laura Martinez
    Sevilla, Teresa
    Garro, Cristina Borrachero
    Martin, Julian Fernandez
    Vicente, Adrian Anton
    de la Prida, Moises Morales
    Davila, Lucia Galan
    Vazquez, Laura Gonzalez
    Valle, Ferran Martinez
    Pons, Carlos Casasnovas
    Bau, Arturo Fraga
    Barroso, Eugenia Cisneros
    Lopez, Ines Losada
    Gonzalez-Moreno, Juan
    MEDICINA CLINICA, 2024, 162 (09): : e27 - e32
  • [19] Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met)
    Ando, Y
    Ando, E
    Ohlsson, PI
    Olofsson, A
    Sandgren, O
    Suhr, O
    Terazaki, H
    Obayashi, K
    Lundgren, E
    Ando, M
    Negi, A
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (02): : 119 - 123
  • [20] Comparison of quantitative sensory testing and heart rate variability in Swedish Val30Met ATTR
    Heldestad, Victoria
    Wiklund, Urban
    Hornsten, Rolf
    Obayashi, Konen
    Suhr, Ole B.
    Nordh, Erik
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 (04): : 183 - 190